Morgan Stanley upgrades Qorvo to Overweight with a $106 price target, projecting $9.63 EPS by 2026 and strong margins through strategic focus.
Latest Ratings for QRVO
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Mar 2022 | Morgan Stanley | Downgrades | Overweight | Equal-Weight |
| Feb 2022 | Benchmark | Maintains | Buy | |
| Feb 2022 | Mizuho | Maintains | Neutral |
